AI ALLR Forecast


Bullish Case: Positive trial results for stenoparib could significantly enhance investor confidence, spurring substantial price gains for ALLR. With the right strategic partnerships, legitimacy in oncology can be established, propelling further upward momentum.


Bearish Case: Continued negative results or delays in FDA trials may further erode investor sentiment, catalyzing significant price declines. Persistent financial issues could raise doubts about ALLR's long-term viability, amplifying downside risk.


Potential Outcomes:

1) Positive FDA trial approval for stenoparib (15%);

2) Negative Phase 3 results (30%);

3) Acquisition or merger activity (5%);

4) Market rebounds boosting investor interest (20%);

5) Ongoing financial struggles (30%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


September 17, 2024


Allarity Therapeutics Forecast

ALLR      Allarity Therapeutics











Correlated Assets

Assets that tend to move strongly with ALLR



FNGR Forecast + Options Trading Strategies   FNGR  FingerMotion (0.71)


MP Forecast + Options Trading Strategies   MP  MP Materials (0.68)


RILY Forecast + Options Trading Strategies   RILY  B. Riley Financial (0.65)


WEAT Forecast + Options Trading Strategies   WEAT  Teucrium Wheat (0.65)


EQT Forecast + Options Trading Strategies   EQT  EQT (0.64)



Uncorrelated Assets

Assets with little price relationship to ALLR



FVRR Forecast + Options Trading Strategies   FVRR  Fiverr (-0.0)


RIOT Forecast + Options Trading Strategies   RIOT  Riot Blockchain (-0.0)


PCOR Forecast + Options Trading Strategies   PCOR  Procore (0.0)


EQX Forecast + Options Trading Strategies   EQX  Equinox Gold (0.0)


BEP Forecast + Options Trading Strategies   BEP  Brookfield Renewable (-0.0)



Anticorrelated Assets

Assets that tend to move strongly against ALLR



CHKP Forecast + Options Trading Strategies   CHKP  Check Point Software Technolgies (-0.63)


BURL Forecast + Options Trading Strategies   BURL  Burlington Stores (-0.63)


MDGL Forecast + Options Trading Strategies   MDGL  Madrigal Pharmaceuticals (-0.64)


INFY Forecast + Options Trading Strategies   INFY  Infosys (-0.65)


CRDO Forecast + Options Trading Strategies   CRDO  CRDO (-0.66)





Become a more profitable investor with AI optimized trading strategies






×

Chat with ALLR


 Ask any question about ALLR!